razoxane has been researched along with Blood Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engstrom, PF; Klaassen, DJ; MacIntyre, JM; Mittelman, A | 1 |
| Hassenstein, E; Rhomberg, W | 1 |
| Chachoua, A; Green, M; Muggia, F; Wernz, J | 1 |
| Earhart, RH; Glaubiger, DL; Gribble, TJ; Holcenberg, JS; Kamen, BA; Pratt, CB; Tutsch, KD; Ungerleider, RS | 1 |
| Bhat, HB; Ferrans, VJ; Herman, EH; Witiak, DT | 1 |
2 trial(s) available for razoxane and Blood Diseases
| Article | Year |
|---|---|
Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; Drug Administration Schedule; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hydroxyurea; Male; Middle Aged; Mitomycins; Random Allocation; Razoxane; Rectal Neoplasms; Semustine; Time Factors | 1984 |
[Combined treatment of lung carcinoma. Report on a prospective randomized study with radiotherapy and ICRF 159 (1,2-(3,5-dioxopiperazines-lyl)propane) (author's transl)].
Topics: Adenocarcinoma; Adult; Aged; Bronchial Neoplasms; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Female; Hematologic Diseases; Humans; Male; Middle Aged; Piperazines; Radioisotope Teletherapy; Radiotherapy Dosage; Radiotherapy, High-Energy; Razoxane | 1977 |
3 other study(ies) available for razoxane and Blood Diseases
| Article | Year |
|---|---|
Phase II trial of ICRF-187 in patients with acquired immune deficiency related Kaposi's sarcoma (AIDS-KS).
Topics: Acquired Immunodeficiency Syndrome; Drug Evaluation; Drugs, Investigational; Hematologic Diseases; Humans; Male; Middle Aged; Piperazines; Razoxane; Sarcoma, Kaposi; Stereoisomerism | 1989 |
Phase I study of ICRF-187 in pediatric cancer patients and comparison of its pharmacokinetics in children and adults.
Topics: Adolescent; Adult; Blood Coagulation Tests; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Enzymes; Half-Life; Hematologic Diseases; Humans; Kinetics; Neoplasms; Piperazines; Razoxane; Stereoisomerism; Tissue Distribution | 1986 |
Reduction of chronic doxorubicin cardiotoxicity in beagle dogs by bis-morpholinomethyl derivative of razoxane (ICRF-159).
Topics: Animals; Blood Cell Count; Body Weight; Dogs; Doxorubicin; Drug Evaluation, Preclinical; Female; Heart Diseases; Hematocrit; Hematologic Diseases; Male; Piperazines; Razoxane | 1987 |